SomesTech

SomesTech (Zhongke Baicheng) is an innovative biotechnology company incubated by the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences. Founded in 2022, the company specializes in developing advanced drug nanocarriers and high-end biomedical devices for exosome-based drug delivery. SomesTech's core technologies include the ExoLoad© platform, a microfluidic precision control system that enables automated, high-throughput, and efficient loading of therapeutic payloads (such as small molecules, nucleic acids, proteins, and peptides) into exosomes. Through its strategic joint venture, XomeXBio, with Belgian biopharma company convEyXO, SomesTech is scaling up its nanoengineering platform to meet pharmaceutical standards and accelerate the clinical translation of loaded exosome therapeutics globally.